Abstract
Three licensed and three research human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay (EIA) kits were evaluated with a panel of 213 serum or plasma samples which were previously tested by the indirect immunofluorescence method for HTLV-I and -II antibodies. The three research kits were found to be more sensitive and specific than the three licensed kits.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gallo D., Diggs J. L., Hanson C. V. Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II. J Clin Microbiol. 1990 Sep;28(9):2045–2050. doi: 10.1128/jcm.28.9.2045-2050.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallo D., Hoffman M. N., Cossen C. K., Diggs J. L., Hurst J. W., Penning L. M. Comparison of immunofluorescence, enzyme immunoassay, and Western blot (immunoblot) methods for detection of antibody to human T-cell leukemia virus type I. J Clin Microbiol. 1988 Aug;26(8):1487–1491. doi: 10.1128/jcm.26.8.1487-1491.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hjelle B., Scalf R., Swenson S. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood. 1990 Aug 1;76(3):450–454. [PubMed] [Google Scholar]
- Kline R. L., Brothers T., Halsey N., Boulos R., Lairmore M. D., Quinn T. C. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II. Lancet. 1991 Jan 5;337(8732):30–33. doi: 10.1016/0140-6736(91)93343-8. [DOI] [PubMed] [Google Scholar]
- Kwok S., Gallo D., Hanson C., McKinney N., Poiesz B., Sninsky J. J. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses. 1990 Apr;6(4):561–565. doi: 10.1089/aid.1990.6.561. [DOI] [PubMed] [Google Scholar]
- Lee H. H., Weiss S. H., Brown L. S., Mildvan D., Shorty V., Saravolatz L., Chu A., Ginzburg H. M., Markowitz N., Des Jarlais D. C. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis. 1990 Aug;162(2):347–352. doi: 10.1093/infdis/162.2.347. [DOI] [PubMed] [Google Scholar]
- Lee H., Swanson P., Shorty V. S., Zack J. A., Rosenblatt J. D., Chen I. S. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science. 1989 Apr 28;244(4903):471–475. doi: 10.1126/science.2655084. [DOI] [PubMed] [Google Scholar]
- Robert-Guroff M., Weiss S. H., Giron J. A., Jennings A. M., Ginzburg H. M., Margolis I. B., Blattner W. A., Gallo R. C. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986 Jun 13;255(22):3133–3137. [PubMed] [Google Scholar]